# Viva Biotech Holdings (VBIZF)

> Healthcare · CN · Reports in CNY

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/VBIZF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | ¥ 1.71B | ¥ 218.13M | ¥ 99.97M | ¥ 1.33B | ¥ 4.00B |
| 2024 | ¥ 2.00B | ¥ 168.11M | ¥ 184.20M | ¥ 1.28B | ¥ 3.80B |
| 2023 | ¥ 2.17B | ¥ -116.79M | ¥ 196.87M | ¥ 1.90B | ¥ 3.69B |
| 2022 | ¥ 2.39B | ¥ -530.01M | ¥ 137.12M | ¥ 2.82B | ¥ 3.60B |
| 2021 | ¥ 2.15B | ¥ 293.50M | ¥ -497.44M | ¥ 2.65B | ¥ 3.91B |
| 2020 | ¥ 721.65M | ¥ -400.58M | ¥ -568.91M | ¥ 2.97B | ¥ 3.76B |
| 2019 | ¥ 335.40M | ¥ 276.03M | ¥ -10.56M | ¥ 49.41M | ¥ 1.78B |
| 2018 | ¥ 227.68M | ¥ 98.16M | ¥ -37.72M | ¥ 222.96M | ¥ 251.44M |
| 2017 | ¥ 156.96M | ¥ 71.08M | N/A | N/A | N/A |
| 2016 | ¥ 110.55M | ¥ 49.79M | N/A | N/A | N/A |
| 2015 | ¥ 27.14M | ¥ 6.88M | ¥ 3.88M | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.33 |
| Liabilities / Eq | 0.80 |
| Current Ratio | 1.50 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 104.48 |

## Other views

- [Metrics](https://sponda.capital/en/VBIZF.md)
- [Charts](https://sponda.capital/en/VBIZF/charts.md)
- [Compare](https://sponda.capital/en/VBIZF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.